• Home

  • Documents

  • Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for...
112

Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease

Embed Size (px)

Citation preview

Page 1: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 2: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 3: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 4: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 5: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 6: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 7: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 8: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 9: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 10: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 11: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 12: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 13: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 14: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 15: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 16: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 17: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 18: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 19: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 20: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 21: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 22: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 23: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 24: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 25: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 26: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 27: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 28: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 29: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 30: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 31: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 32: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 33: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 34: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 35: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 36: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 37: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 38: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 39: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 40: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 41: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 42: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 43: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 44: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 45: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 46: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 47: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 48: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 49: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 50: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 51: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 52: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 53: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 54: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 55: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 56: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 57: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 58: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 59: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 60: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 61: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 62: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 63: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 64: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 65: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 66: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 67: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 68: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 69: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 70: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 71: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 72: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 73: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 74: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 75: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 76: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 77: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 78: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 79: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 80: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 81: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 82: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 83: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 84: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 85: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 86: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 87: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 88: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 89: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 90: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 91: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 92: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 93: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 94: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 95: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 96: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 97: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 98: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 99: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 100: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 101: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 102: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 103: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 104: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 105: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 106: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 107: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 108: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 109: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 110: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 111: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease
Page 112: Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease

Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration

Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration

Documents
NOVEL GENES RELATED TO GLUTAMINYL CYCLASE

NOVEL GENES RELATED TO GLUTAMINYL CYCLASE

Documents
Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Aβ is induced by pyroglutamate-Aβ formation

Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Aβ is induced by pyroglutamate-Aβ formation

Documents
Laminin affects polymerization, depolymerization and neurotoxicity of Aβ peptide

Laminin affects polymerization, depolymerization and neurotoxicity of Aβ peptide

Documents
Monoclonal antibodies that target pathological assemblies of Aβ

Monoclonal antibodies that target pathological assemblies of Aβ

Documents
The Effect of Curcumin on the Stability of Aβ Dimers

The Effect of Curcumin on the Stability of Aβ Dimers

Documents
Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-beta Load and Cognitive Decline in Alzheimer's Disease

Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-beta Load and Cognitive Decline in Alzheimer's Disease

Documents
Cell fractionation, detergent sensitivity and solubilization of Dictyostelium adenylate cyclase and guanylate cyclase

Cell fractionation, detergent sensitivity and solubilization of Dictyostelium adenylate cyclase and guanylate cyclase

Documents
Use of effectors of glutaminyl and glutamate cyclases for therapy

Use of effectors of glutaminyl and glutamate cyclases for therapy

Documents
18F-florbetaben Aβ imaging in mild cognitive impairment

18F-florbetaben Aβ imaging in mild cognitive impairment

Documents
Amyloidogenic Processing of Amyloid Precursor Protein: Evidence of a Pivotal Role of Glutaminyl Cyclase in Generation of Pyroglutamate-Modified Amyloid-β †

Amyloidogenic Processing of Amyloid Precursor Protein: Evidence of a Pivotal Role of Glutaminyl Cyclase in Generation of Pyroglutamate-Modified Amyloid-β †

Documents
Adult Type 3 Adenylyl Cyclase-Deficient Mice Are Obese

Adult Type 3 Adenylyl Cyclase-Deficient Mice Are Obese

Documents
An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway

An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway

Documents
Studies on the in Vitro Assembly of Aβ 1–40: Implications for the Search for Aβ Fibril Formation Inhibitors

Studies on the in Vitro Assembly of Aβ 1–40: Implications for the Search for Aβ Fibril Formation Inhibitors

Documents
Preparation of glutaminyl cyclase inhibitors for use in treating neurological diseases

Preparation of glutaminyl cyclase inhibitors for use in treating neurological diseases

Documents
Preparation of imidazolyl thiourea derivatives as inhibitors of glutaminyl cyclase

Preparation of imidazolyl thiourea derivatives as inhibitors of glutaminyl cyclase

Documents
Non-Aβ Component of Alzheimer's Disease Amyloid (NAC) Revisited

Non-Aβ Component of Alzheimer's Disease Amyloid (NAC) Revisited

Documents
Heterologous Expression and Characterization of Human Glutaminyl Cyclase:  Evidence for a Disulfide Bond with Importance for Catalytic Activity

Heterologous Expression and Characterization of Human Glutaminyl Cyclase:  Evidence for a Disulfide Bond with Importance for Catalytic Activity

Documents
Inhibition of glutaminyl cyclase prevents pGlu-A formation after intracorticalhippocampal microinjection in vivo in situ

Inhibition of glutaminyl cyclase prevents pGlu-A formation after intracorticalhippocampal microinjection in vivo in situ

Documents
Effects of amyloid-beta (Aβ) on homeostatic network plasticity

Effects of amyloid-beta (Aβ) on homeostatic network plasticity

Documents
Guanylate-cyclase-inhibitory protein is a frog retinal Ca2+-binding protein related to mammalian guanylate-cyclase-activating proteins

Guanylate-cyclase-inhibitory protein is a frog retinal Ca2+-binding protein related to mammalian guanylate-cyclase-activating proteins

Documents
Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization †

Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization †

Documents
Molecular Characterization of a Novel Intracellular ADP-Ribosyl Cyclase

Molecular Characterization of a Novel Intracellular ADP-Ribosyl Cyclase

Documents
Effects of cadmium on renal cortical adenylate cyclase

Effects of cadmium on renal cortical adenylate cyclase

Documents
Adult Type 3 Adenylyl Cyclase–Deficient Mice Are Obese

Adult Type 3 Adenylyl Cyclase–Deficient Mice Are Obese

Documents
Thyrotropin Receptor-Adenylate Cyclase Function in Human Thyroid Neoplasms

Thyrotropin Receptor-Adenylate Cyclase Function in Human Thyroid Neoplasms

Documents
SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer' Disease: The Role of the Immune System in Clearance of Aβ from the Brain

SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer' Disease: The Role of the Immune System in Clearance of Aβ from the Brain

Documents
N-cadherin-based adhesion enhances Aβ release and decreases Aβ 42/40 ratio

N-cadherin-based adhesion enhances Aβ release and decreases Aβ 42/40 ratio

Documents
Methods of diagnosing inflammatory diseases by determining pyroglutamate- modified MCP- 1 and screening methods for inhibitors of glutaminyl cyclase

Methods of diagnosing inflammatory diseases by determining pyroglutamate- modified MCP- 1 and screening methods for inhibitors of glutaminyl cyclase

Documents
A transgenic rat model of Alzheimer's disease with extracellular Aβ deposition

A transgenic rat model of Alzheimer's disease with extracellular Aβ deposition

Documents